ArticleJournal of medicinal chemistry2022

Next-Generation Diprovocims with Potent Human and Murine TLR1/TLR2 Agonist Activity That Activate the Innate and Adaptive Immune Response.

Ming-Hsiu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.